NeueHealth Expects 2024 Adjusted EBITDA Of $15M-$25M
Portfolio Pulse from Benzinga Newsdesk
NeueHealth projects its adjusted EBITDA for 2024 to be between $15M and $25M.
May 08, 2024 | 10:51 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NeueHealth expects its 2024 adjusted EBITDA to be in the range of $15M to $25M.
The projection of adjusted EBITDA by NeueHealth indicates a positive financial outlook for the company, which can lead to increased investor confidence and potentially a rise in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100